REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options & Conversion of Outstanding Debt

13 Apr 2011 07:00

RNS Number : 7995E
Fitbug Holdings PLC
13 April 2011
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

 

Fitbug Holdings Plc ('Fitbug' or 'the Company')

Grant of Options, Conversion of Outstanding Debt and

Change of Registered Office

 

Fitbug Holdings Plc, the AIM traded provider of online personal health and well-being services, is pleased to announce the grant of share options to certain directors of the Company, the conversion of a significant portion of outstanding debt into equity and a change of the Company's registered office.

 

Grant of Options

 

Fitbug has, on 12 April 2011, granted share options under its Enterprise Management Incentive ('EMI') Scheme over 12,000,000 1 pence ordinary shares to certain directors of the Company. The options are exercisable at three prices: 4,000,000 at 5 pence per share, 4,000,000 at 7.5 pence per share and 4,000,000 at 10 pence per share. The share options have been granted as follows:

 

Director

Position

Number of Options granted

Total number of Options held

Fergus Kee

Executive Chairman - Fitbug Holdings Plc

4,500,000

4,500,000

David Turner

Chief Executive

- Fitbug Holdings Plc

3,000,000

3,100,000

Paul Landau

Chief Executive

- Fitbug Ltd

4,500,000

5,500,000

TOTAL

12,000,000*

13,100,000

* exercisable at 5 pence, 7.5 pence and 10 pence pro-rata to number of options individually granted

 

All 12,000,000 options are subject to an overall condition that no options can be exercised until the Fitbug share price moves above 15 pence.

 

Conversion of Outstanding Debt

Further to the announcement of 21 March 2011, the Company has agreed with NW1 Investments Ltd ('NW1') to convert £175,000 of outstanding debt to 3,500,000 ordinary shares at a price of 5 pence and to absolve the accrued outstanding interest of £75,000. The Company has also agreed that terms of the remaining £325,000 loan be amended to be repayable in five equal annual instalments from 1 April 2012 through to 1 April 2016. All interest will accrue to the end of the loan term and become payable on 1 April 2016.

 

Following the conversion of the debt to equity, certain shareholders of NW1 have informed the Company that they now have an interest in the Company as follows:

 

Shareholder

Interest Shares

% of issued share capital

David Turner and immediate family

16,503,333

14.80%

Allan Fisher and immediate family

15,503,333

13.91%

 

The independent directors of the Company, being Fergus Kee, Geoffrey Simmonds, Paul Landau and Andrew Brummer, consider, having consulted with Seymour Pierce, that the conversion of debt for equity are fair and reasonable in so far as the shareholders are concerned.

 

Fitbug Executive Chairman Fergus Kee said, "These options strongly align the interests of senior executives and shareholders, demonstrating our belief in Fitbug's potential, particularly in North America. The exercise prices, and in particular the condition that no options can be exercised until the share price moves above 15 pence, reflect our ambition and confidence for the future of Fitbug, and rightly sets a high bar for the Company.

 

"Importantly, the agreement with NW1 contributes £250,000 to our balance sheet, strengthening it significantly, and the revised loan terms give greater certainty and security regarding future funding."

 

Application has been made to the London Stock Exchange for admission of the 3,500,000 new ordinary shares to be admitted to trading on AIM. Admission is expected to occur on 20 April 2011.

 

For the purposes of the Disclosure and Transparency Rules, Fitbug's total issued share capital following the issue of these shares consists of 111,487,194 ordinary shares of 1 penny each.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Fitbug, under the Disclosure and Transparency Rules.

 

Change of Registered Address

The Company also announces that its registered office has changed with immediate effect to 1st Floor, Waterside House, 47-49 Kentish Town Road, London, NW1 8NX.

 

* * ENDS * *

 

 For further information visit www.fitbugholdings.com or contact:

 

Andrew Brummer

Fitbug Holdings Plc

Tel: 020 7449 1000

Mark Percy

Seymour Pierce

Tel: 020 7107 8000

Catherine Leftley

Seymour Pierce

Tel: 020 7107 8000

Jon Levinson

Rivington Street Corporate Finance Limited

Tel: 020 7562 3357

Isabel Crossley

St Brides Media & Finance Ltd

Tel: 020 7236 1177

Elisabeth Cowell

St Brides Media & Finance Ltd

Tel: 020 7236 1177

 

Notes

 

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to fitbug.com to provide an understanding of each user's daily activity achievements, with web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement. 

 

Key market sectors include health insurance and rewards providers, workplace health programmes, Primary Care Trusts, fitness operators and consumers. Increasingly, Fitbug's platform acts as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes.

 The Company's main focus is now on building strategic partnerships with organisations which can integrate Fitbug into their own service/product offerings or resell to their customer base.  

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUBWCUPGGMP
Date   Source Headline
23rd Apr 20247:00 amRNSCancellation - Bidstack Group PLC
22nd Mar 20241:11 pmRNSAppointment of Administrators & Nomad Resignation
11th Mar 20247:30 amRNSSuspension - Bidstack Group PLC
11th Mar 20247:00 amRNSIntention to Appoint Administrators & Suspension
5th Feb 20247:00 amRNSUpdate on CLN, Financial Update & Strategic Review
22nd Dec 20237:00 amRNSSettlement & new commercial partnership - Azerion
1st Nov 20237:00 amRNSChange of Registered Office
18th Oct 20233:45 pmRNSProposed CLN, Share Reorganisation and VST Update
29th Sep 20237:00 amRNSBoard Change
29th Sep 20237:00 amRNSProposed New Commercial Partnership
29th Sep 20237:00 amRNSInterim Results
30th Aug 20237:00 amRNSVenatus Advertising Sales Partnership
23rd Aug 20234:47 pmRNSTR-1: Notification of Major Holdings
21st Jul 202311:23 amRNS2023 Annual General Meeting Results
18th Jul 202311:46 amRNSGeneral Meeting Requisition Request withdrawn
18th Jul 20237:00 amRNSBoard Changes
13th Jul 20231:32 pmRNSVirtual stadium partnership with first NFL team
11th Jul 20237:00 amRNSRequisitioned General Meeting
5th Jul 20237:00 amRNSRequest to requisition a General Meeting
21st Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
20th Jun 20238:18 amRNSFinal Results and Annual Report - replacement
20th Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
1st Mar 20235:28 pmRNSComment on Azerion Statement
15th Feb 20237:00 amRNSBidstack appoints Thomas Bullen as CFO
13th Feb 20232:05 pmRNSSecond Price Monitoring Extn
13th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20237:00 amRNSTrading and Operational Update
18th Jan 202311:22 amRNSChange of Registered Office
3rd Jan 202311:05 amRNSSecond Price Monitoring Extn
3rd Jan 202311:00 amRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSAzerion Update
29th Dec 20227:00 amRNSBoard Changes
9th Dec 202211:04 amRNSGrant of LTIP Options
8th Dec 20227:00 amRNSExercise of Options, Issue of Equity & TVR
6th Dec 202211:03 amRNSTR-1: Notification of major holdings
5th Dec 20227:00 amRNSBidstack adds 2 titles with a AAA game publisher
1st Nov 20223:39 pmRNSTR-1: Notification of major holdings
31st Oct 20223:35 pmRNSTotal Voting Rights
31st Oct 20223:21 pmRNSTR-1: Notification of major holdings
31st Oct 20222:16 pmRNSTR-1: Notification of major holdings
31st Oct 202211:54 amRNSTR-1: Notification of major holdings
28th Oct 20224:16 pmRNSTR-1: Notification of Major Holdings
28th Oct 20227:00 amRNSUpdate re Press Commentary
26th Oct 20223:45 pmRNSAdmission of Ordinary Shares and TVR
26th Oct 20227:00 amRNSStrategy Update
25th Oct 202212:08 pmRNSResults of General Meeting
13th Oct 20227:00 amRNSBidstack appoints Camila Franklin as COO
6th Oct 20226:28 pmRNSResults of REX Retail Offer
6th Oct 20228:06 amRNSResults of Placing and Subscription
5th Oct 20224:36 pmRNSREX Retail Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.